Shanghai Ouyi Biomedical Technology

About:

Shanghai Ouyi Biomedical Technology is a provider of gene sequencing services.

Website: https://www.oebiotech.com

Top Investors: Sinopharm Capital, Orient Securities Capital Investment

Description:

Shanghai Ouyi Biomedical Technology Co., Ltd., established in 2009, is a high-tech enterprise of multi-omics testing services with "specialization, specialization and new". It has built a multi-omics testing platform covering nucleic acid, protein, and metabolism. Big data analysis platform combined with multi-omics. For pharmaceutical, food and daily chemical companies; life sciences, medicine and clinical research fields, provide drug target discovery, pharmacological efficacy and safety evaluation, disease molecular marker screening, pathogenic bacteria and drug resistance traceability, life development research and Multi-level and multi-omics testing services and solutions for disease occurrence and development research.